All lobbying filings

SPLITOAK STRATEGIES LLC

Lobbying for JOHNSON & JOHNSON SERVICES, INC. · Global biopharmaceutical, medical device and consumer product manufacturer.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 21, 2025

Official filing document

Bills named in this filing 3

HR 946
ORPHAN Cures Act
S 1862
ORPHAN Cures Act
HR 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025

Lobbying activity 1

Medicare/Medicaid

Value of prescription drugs and patient access Issues related to Medicare Parts B & D P.L. 119-21 H.R. 946/S. 1862, ORPHAN Cures Act H.R. 2483, SUPPORT Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.